Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFALIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 157 adverse event reports in the FDA FAERS database where EFALIZUMAB was used for Psoriasis.

Most Reported Side Effects for EFALIZUMAB

Side Effect Reports % Deaths Hosp.
Death 56 24.4% 56 2
Psoriasis 55 23.9% 3 13
Pruritus 35 15.2% 8 1
Erythema 28 12.2% 4 0
Drug ineffective 26 11.3% 3 6
Pain 25 10.9% 10 1
Decreased appetite 24 10.4% 0 0
Hypersensitivity 24 10.4% 1 1
Vomiting 24 10.4% 0 2
Nausea 23 10.0% 1 0
Condition aggravated 22 9.6% 0 8
Myalgia 22 9.6% 0 0
Fatigue 20 8.7% 0 0
Skin exfoliation 19 8.3% 5 0
Skin plaque 12 5.2% 6 0

Other Indications for EFALIZUMAB

Pustular psoriasis (101) Product used for unknown indication (51) Psoriatic arthropathy (8)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

EFALIZUMAB Full Profile All Psoriasis Drugs EFALIZUMAB Demographics EFALIZUMAB Timeline